ABBISKO-B：(1)ANNUALRESULTSANNOUNCEMENTFORTHEYEARENDEDDECEMBER312024;(2)CHANGEINUSEOFNETPROCEEDS;(3)INSIDEINFORMATION;AND(4)CHANGEINCOMPOSITIONOFTHEBOARD.pdf

《ABBISKO-B：(1)ANNUALRESULTSANNOUNCEMENTFORTHEYEARENDEDDECEMBER312024;(2)CHANGEINUSEOFNETPROCEEDS;(3)INSIDEINFORMATION;AND(4)CHANGEINCOMPOSITIONOFTHEBOARD.pdf》由会员分享，可在线阅读，更多相关《ABBISKO-B：(1)ANNUALRESULTSANNOUNCEMENTFORTHEYEARENDEDDECEMBER312024;(2)CHANGEINUSEOFNETPROCEEDS;(3)INSIDEINFORMATION;AND(4)CHANGEINCOMPOSITIONOFTHEBOARD.pdf（46页珍藏版）》请在三个皮匠报告上搜索。

1、1Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in relia

2、nce upon the whole or any part of the contents of this announcement.Abbisko Cayman Limited和 譽 開 曼 有 限 責 任 公 司(Incorporated in the Cayman Islands with limited liability)(Stock Code:2256)(1)ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31,2024;(2)CHANGE IN USE OF NET PROCEEDS;(3)INSIDE INFOR

3、MATION;AND(4)CHANGE IN COMPOSITION OF THE BOARDThe Board announces on March 3,2025:(1)the consolidated annual results of the Company and its subsidiaries for the year ended December 31,2024,together with comparative figures for the year ended December 31,2023;(2)to change the use of unutilised net p

4、roceeds from the Global Offering;(3)that Dr.Chen Zhui(陳椎)has resigned as an executive Director of the Company with effect from March 3,2025,and our other current chief scientific officer and our executive Director,Dr.Yu Hongping(喻紅平),will continue to lead our R&D efforts;(4)that Dr.Xu Yao-Chang,Dr.Y

5、u Hongping and Dr.Chen Zhui entered into a Termination Agreement to terminate the Acting-in-concert Agreement with effect from March 3,2025;and(5)that Dr.Ji Jing(嵇靖)has been appointed as an executive Director of the Company with effect from March 3,2025.The board of directors(the“Board”)of Abbisko C

6、ayman Limited(the“Company”)is pleased to announce the consolidated annual results of the Company and its subsidiaries(the“Group”,“we”,“our”or“us”)for the year ended December 31,2024(the“Reporting Period”),together with comparative figures for the year ended December 31,2023.2BUSINESS HIGHLIGHTSWe ha